Definition of the viral targets of protective HIV-1-specific T cell responses

BACKGROUND: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction of responses with the most potent antiviral activity and broad HLA class I restriction. However, current HIV vaccine designs are largely based on viral sequence alignments only, not incorporating exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mothe, Beatriz, Llano, Anuska, Ibarrondo, Javier, Daniels, Marcus, Miranda, Cristina, Zamarreño, Jennifer, Bach, Vanessa, Zuniga, Rosario, Pérez-Álvarez, Susana, Berger, Christoph T, Puertas, Maria C, Martinez-Picado, Javier, Rolland, Morgane, Farfan, Marilu, Szinger, James J, Hildebrand, William H, Yang, Otto O, Sanchez-Merino, Victor, Brumme, Chanson J, Brumme, Zabrina L, Heckerman, David, Allen, Todd M, Mullins, James I, Gómez, Guadalupe, Goulder, Philip J, Walker , Bruce D, Gatell, Jose M, Clotet, Bonaventura, Korber, Bette T, Sanchez, Jorge, Brander, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292987/
https://www.ncbi.nlm.nih.gov/pubmed/22152067
http://dx.doi.org/10.1186/1479-5876-9-208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292987/
https://www.ncbi.nlm.nih.gov/pubmed/22152067
http://dx.doi.org/10.1186/1479-5876-9-208

Ejemplares similares